Psychopharmacological and Therapeutic Strategies in Child and Adolescent Psychiatry

Experts in pediatric psychopharmacology and the treatment of children and adolescents with psychiatric or sleep disorders will present updated and evidence based treatments. The educational learning objective of this activity is to increase your skills in evaluating and making appropriate psychopharmacological and therapeutic decisions for children and adolescents with ADHD and mood, anxiety, psychosis, obsessive compulsive, tic and sleep disorders.

The conference has been designed for child, adolescent and adult psychiatrists, pediatricians, pediatric neurologists, psychologists, psychotherapists and trainees who treat children and adolescents for these conditions. The conference is cosponsored by the Israel Association of Child and Adolescent Psychiatry and the Albert Einstein College of Medicine of Yeshiva University.

CME credit will be available from the Albert Einstein College of Medicine.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Albert Einstein College of Medicine designates this educational activity for a maximum of 18 Category 1 credits towards the AMA Physicians Recognition AwardTM. Each physician should claim only those credits commensurate with the extent of their participation in the activity.